Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Antares Pharma revenue
Antares Pharma's revenue is $184.0 million.
What is Antares Pharma's revenue?
- Antares Pharma's revenue growth from 2002 to 2021 is 4,504.43%.
- Antares Pharma has 165 employees, and the revenue per employee ratio is $1,115,042.
- Antares Pharma's peak quarterly revenue was $48.7M in 2021(q4).
- Antares Pharma peak revenue was $184.0M in 2021.
- Antares Pharma annual revenue for 2020 was 149.6M, 20.78% growth from 2019.
- Antares Pharma annual revenue for 2021 was 184.0M, 22.98% growth from 2020.
On this page
Zippi applies for you, and finds you a job.
Antares Pharma historical revenue
Antares Pharma's peak revenue was $184.0M in 2021. The peak quarterly revenue was $48.7M in 2021(q4).
Antares Pharma's revenue increased from $4.0m in 2002 to $184.0M currently. That's a 4,504.43% change in annual revenue.
Antares Pharma annual revenue
Antares Pharma annual revenue over time
| Fiscal year / year | Antares Pharma revenue |
|---|---|
| 2009 | $8.3M |
| 2010 | $12.8M |
| 2011 | $16.5M |
| 2012 | $22.6M |
| 2013 | $20.6M |
| 2014 | $26.5M |
| 2015 | $45.7M |
| 2016 | $52.2M |
| 2017 | $54.5M |
| 2018 | $63.6M |
| 2019 | $123.9M |
| 2020 | $149.6M |
| 2021 | $184.0M |
Rate Antares Pharma's financial transparency
Antares Pharma annual growth
Antares Pharma saw the greatest revenue growth in 2006, when revenue increased by 191,760.06%.
Antares Pharma had the lowest revenue growth in 2015, when revenue changed by -99.83%.
Antares Pharma annual growth rate over time
| Year | Antares Pharma growth |
|---|---|
| 2009 | 47%↑ |
| 2010 | 54%↑ |
| 2011 | 28%↑ |
| 2012 | 37%↑ |
| 2013 | -9%↓ |
| 2014 | 29%↑ |
| 2015 | 72%↑ |
| 2016 | 14%↑ |
| 2017 | 4%↑ |
| 2018 | 17%↑ |
| 2019 | 95%↑ |
| 2020 | 21%↑ |
| 2021 | 23%↑ |
Antares Pharma quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Antares Pharma quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2010 | - | - | $3.1M | $3.3M |
| 2011 | $3.6M | $3.5M | $3.9M | $5.4M |
| 2012 | $6.9M | $4.5M | $5.7M | $5.5M |
| 2013 | $4.5M | $5.8M | $5.5M | $4.7M |
| 2014 | $5.2M | $6.3M | $6.6M | $8.4M |
| 2015 | $8.3M | $14.4M | $11.1M | $11.8M |
| 2016 | $12.3M | $12.2M | $13.5M | $14.2M |
| 2017 | $12.0M | $13.4M | $15.1M | $14.0M |
| 2018 | $12.7M | $14.2M | $17.9M | $18.8M |
| 2019 | $23.3M | $28.4M | $34.3M | $37.8M |
| 2020 | $33.1M | $32.4M | $40.0M | $44.1M |
| 2021 | $42.1M | $45.0M | $48.2M | $48.7M |
| 2022 | $41.6M | - | - | - |
Antares Pharma jobs nearby
Do you work at Antares Pharma?
Did Antares Pharma meet its revenue projections?
Antares Pharma financial information
| CEO | Robert F. Apple |
| Company Type | Public |
| Employees Number | 165 |
| Date Founded | 1979 |
| Headquarters | Ewing, New Jersey |
| Number of Locations | 2 |
| Revenue | $184.0M |
| Net Income | $46,289,000 |
| Gross Proft | $115.7M (2021) |
| PE Ratio | 12.28 |
| Tax Rate | 0.3% |
| Market Capitalization | $568.3M |
| Total Assets | $257,505,000 |
| Ticker | ATRS |
Antares Pharma jobs you might like
Antares Pharma financing
Antares Pharma received early financing of $10.0M on 2007-02-28.
| Series | Round size | Date |
|---|---|---|
| Debt Financing | $10M | 02/2007 |
| Post Ipo Debt | $35M | 06/2017 |
Antares Pharma investors
| Investors | Security type |
|---|---|
| MMV FINANCIAL INC. | Debt Financing |
| HSBC Venture Capital Coverage Group | Debt Financing |
| HERCULES CAPITAL INC | Post Ipo Debt |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Antares Pharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Antares Pharma. The employee data is based on information from people who have self-reported their past or current employments at Antares Pharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Antares Pharma. The data presented on this page does not represent the view of Antares Pharma and its employees or that of Zippia.
Antares Pharma may also be known as or be related to ANTARES PHARMA INC., Antares Pharma, Antares Pharma Inc, Antares Pharma Inc. and Antares Pharma, Inc.